Beskrovnaya Oxana 4
4 · Dyne Therapeutics, Inc. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
Beskrovnaya Oxana
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2024-12-04+62,400→ 62,400 totalExercise: $29.44Exp: 2034-12-03→ Common Stock (62,400 underlying) - Award
Common Stock
2024-12-04+39,100→ 176,619 total - Award
Common Stock
2024-12-04+27,400→ 204,019 total
Footnotes (4)
- [F1]Consists of shares of Common Stock issuable under 39,100 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 4, 2025.
- [F2]Consists of shares of Common Stock issuable under 27,400 RSUs. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in full on December 4, 2025.
- [F3]Includes 170,705 unvested RSUs.
- [F4]This option was granted on December 4, 2024. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 4, 2028.